Cargando…

A study on the use of imiquimod for the treatment of genital molluscum contagiosum and genital warts in female patients

The clinical effect of imiquimod stems from cytokine-induced activation of the immune system. A randomized study was conducted to study the efficacy and safety of daily applications of 5% imiquimod cream in female patients with external genital warts and molluscum contagiosum (MC). The clearance rat...

Descripción completa

Detalles Bibliográficos
Autor principal: Puri, Neerja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168064/
https://www.ncbi.nlm.nih.gov/pubmed/21938126
http://dx.doi.org/10.4103/2589-0557.62763
_version_ 1782211330727477248
author Puri, Neerja
author_facet Puri, Neerja
author_sort Puri, Neerja
collection PubMed
description The clinical effect of imiquimod stems from cytokine-induced activation of the immune system. A randomized study was conducted to study the efficacy and safety of daily applications of 5% imiquimod cream in female patients with external genital warts and molluscum contagiosum (MC). The clearance rate of lesions was 75% in genital MC patients and 50% in patients with genital warts. Erythema was the commonest adverse reaction seen in 24% patients with the use of 5% imiquimod. Other side effects were excoriation seen in 16% patients, erosions in 10% patients, excoriation in 6% patients and pain was seen in 4% patients.
format Online
Article
Text
id pubmed-3168064
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-31680642011-09-21 A study on the use of imiquimod for the treatment of genital molluscum contagiosum and genital warts in female patients Puri, Neerja Indian J Sex Transm Dis AIDS Original Article The clinical effect of imiquimod stems from cytokine-induced activation of the immune system. A randomized study was conducted to study the efficacy and safety of daily applications of 5% imiquimod cream in female patients with external genital warts and molluscum contagiosum (MC). The clearance rate of lesions was 75% in genital MC patients and 50% in patients with genital warts. Erythema was the commonest adverse reaction seen in 24% patients with the use of 5% imiquimod. Other side effects were excoriation seen in 16% patients, erosions in 10% patients, excoriation in 6% patients and pain was seen in 4% patients. Medknow Publications 2009 /pmc/articles/PMC3168064/ /pubmed/21938126 http://dx.doi.org/10.4103/2589-0557.62763 Text en © Indian Journal of Sexually Transmitted Diseases and AIDS http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Puri, Neerja
A study on the use of imiquimod for the treatment of genital molluscum contagiosum and genital warts in female patients
title A study on the use of imiquimod for the treatment of genital molluscum contagiosum and genital warts in female patients
title_full A study on the use of imiquimod for the treatment of genital molluscum contagiosum and genital warts in female patients
title_fullStr A study on the use of imiquimod for the treatment of genital molluscum contagiosum and genital warts in female patients
title_full_unstemmed A study on the use of imiquimod for the treatment of genital molluscum contagiosum and genital warts in female patients
title_short A study on the use of imiquimod for the treatment of genital molluscum contagiosum and genital warts in female patients
title_sort study on the use of imiquimod for the treatment of genital molluscum contagiosum and genital warts in female patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168064/
https://www.ncbi.nlm.nih.gov/pubmed/21938126
http://dx.doi.org/10.4103/2589-0557.62763
work_keys_str_mv AT purineerja astudyontheuseofimiquimodforthetreatmentofgenitalmolluscumcontagiosumandgenitalwartsinfemalepatients
AT purineerja studyontheuseofimiquimodforthetreatmentofgenitalmolluscumcontagiosumandgenitalwartsinfemalepatients